DLACX
Price
$16.54
Change
+$0.08 (+0.49%)
Updated
Oct 17 closing price
Net Assets
165.15M
GFACX
Price
$74.77
Change
+$0.15 (+0.20%)
Updated
Oct 17 closing price
Net Assets
336.3B
Interact to see
Advertisement

DLACX vs GFACX

Header iconDLACX vs GFACX Comparison
Open Charts DLACX vs GFACXBanner chart's image
BNY Mellon Large Cap Equity Y
Price$16.54
Change+$0.08 (+0.49%)
VolumeN/A
Net Assets165.15M
American Funds Growth Fund of Amer C
Price$74.77
Change+$0.15 (+0.20%)
VolumeN/A
Net Assets336.3B
DLACX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
DLACX vs. GFACX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLACX is a Hold and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 336B vs. DLACX (165M). DLACX pays higher dividends than GFACX: DLACX (0.51) vs GFACX (0.00). DLACX was incepted earlier than GFACX: DLACX (10 years) vs GFACX (25 years). GFACX (1.36) is less costly to investors than DLACX (0.80). DLACX is a more actively managed with annual turnover of: 39.80 vs. GFACX (25.00). GFACX has a lower initial minimum investment than DLACX: GFACX (250) vs DLACX (1000000). GFACX annual gain was more profitable for investors over the last year : 9.19 vs. DLACX (-12.97). GFACX return over 5 years is better than : 30.41 vs. DLACX (-31.47).
DLACXGFACXDLACX / GFACX
Total Expense Ratio0.751.3655%
Annual Report Gross Expense Ratio0.801.3659%
Fund Existence10 years25 years-
Gain YTD10.69317.03363%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets165M336B0%
Annual Yield % from dividends0.510.00-
Returns for 1 year-12.979.19-141%
Returns for 3 years-16.9364.43-26%
Returns for 5 years-31.4730.41-103%
Returns for 10 years-0.3480.29-0%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECEMX17.11N/A
N/A
Parametric Emerging Markets C
JFEAX18.62N/A
N/A
JPMorgan Developed International Value A
TIIRX29.15N/A
N/A
Nuveen Core Equity A
CGTRX9.35N/A
N/A
Columbia Select Large Cap Growth Inst2
AFGZX32.17N/A
N/A
Alger Global Equity Z